JCI - JAK inhibitors in autoinflammation
Current and future status of JAK inhibitors - The Lancet
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences
Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors - Welsch - 2017 - European Journal of Immunology - Wiley Online Library
JAK-STAT inhibitors: Immersing therapeutic approach for management of rheumatoid arthritis - ScienceDirect
The role of JAK/STAT signaling pathway and its inhibitors in diseases - ScienceDirect
Ruxolitinib | CAS 941678-49-5 | InvivoGen
Hypoglycaemia following JAK inhibitor treatment in patients with diabetes | Annals of the Rheumatic Diseases
Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?
Viruses | Free Full-Text | JAK-STAT Pathway: A Novel Target to Tackle Viral Infections
JAK/STAT signaling in hematological malignancies | Oncogene
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology
JAKs and STATs in Immunity, Immunodeficiency, and Cancer | NEJM
JAK inhibitors for Atopic Dermatitis – STAT!
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology
APExBIO - JAK/STAT Signaling - Signaling Pathways
Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia | Inflammation and Regeneration | Full Text
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
JCI - The suppressor of cytokine signaling–1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury
Targeting the JAK/STAT pathway in solid tumors
Understanding STAT3, the intersection of many carcinogenic signaling pathways
The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
